Teladoc Health: A Strong Bull Case

Summary:

- Teladoc recently reported strong Q3 2019 results that beat the top- and bottom-line estimates. Additionally, management raised its full-year 2019 guidance for revenue and visits.

- This under-the-radar telehealth company has a strong bull case and, in my opinion, Teladoc is worthy of investment dollars even at today's price.

- I am long Teladoc, and I plan to stay long the stock.

Teladoc Health's ($TDOC) stock has performed extremely well over the past few years, and 2019 has been more of the same. TDOC shares are outperforming the broader market by almost 40 percentage points over the last 11-plus months.

I believe that the stock still has room to run, especially if you are willing (and able) to hold on to shares for the next few years. This under-the-radar company not only has a bullish long-term story to tell, but it also has promising near-term business prospects. And Teladoc's recently reported results (and management commentary) prove it.